A Pilot Study to Determine if Intravitreal Injections of Pegaptanib Sodium (Macugen) Given Every 12 Weeks for a Year After an Induction Phase of Three Injections Every 6 Weeks Will Reduce the Progression of Proliferative Diabetic Retinopathy in Patients Without Significant Vitreous Hemorrhage in Comparison to Treatment With Retinal Photocoagulation Alone and After an Induction Phase
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Pegaptanib (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms M-PDRS ED
- 09 Dec 2011 New trial record